Operating Company Healthcare

Premier Biotech

Minneapolis, Minnesota, United States

Manufacturer of rapid drug testing diagnostic devices and an R&D focused provider of laboratory testing solutions, including CAP forensic-accredited lab services, for workplace, government, and healthcare customers.

Focus Areas
Drug & alcohol testing, Oral fluid toxicology testing, Rapid diagnostic devices

Tracked deals

5

5 tracked deals across 2024-2026.

Recent pace

3

3 tracked deals announced in the last 12 months.

Deal mix

Addon

4 addon · 1 buyout

Premier Biotech Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for Premier Biotech. 1 2024 1 2025 ~4 est. 3 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • Premier Biotech Acquires NexScreen and TransMed
    June 19, 2026
    Buyer
    Premier Biotech, Align Capital Partners
    Target
    NexScreen, TransMed
    Industry
    Healthcare Services
    Location
    Ohio, United States
    Type
    Addon

    Premier Biotech (backed by Align Capital Partners) announced the acquisitions of NexScreen and TransMed to expand its drug and alcohol testing diagnostic product portfolio and global footprint. The deals add NexScreen’s point-of-care diagnostic testing presence in Australia and New Zealand and TransMed’s drug testing product catalog, e-commerce platform, and direct customer base.

  • Premier Biotech Acquires NexScreen and TransMed
    June 18, 2026
    Buyer
    Premier Biotech, Align Capital Partners
    Target
    NexScreen, TransMed
    Seller
    John Debrovner (CEO of NexScreen), Ted Bernhardt (owner of TransMed)
    Industry
    Healthcare Services
    Location
    Minnesota, United States
    Type
    Addon

    Align Capital Partners-backed Premier Biotech announced the acquisitions of NexScreen and TransMed to expand its product portfolio, e-commerce capabilities, and global footprint. NexScreen adds point-of-care diagnostic testing presence in Australia and New Zealand, while TransMed strengthens Premier’s catalog and online distribution to 1,000+ direct customer accounts.

  • Premier Biotech Acquires GH Solutions to Expand Point-of-Care Testing Presence
    April 9, 2026
    Buyer
    Premier Biotech, Align Capital Partners
    Target
    GH Solutions
    Industry
    Healthcare Services
    Location
    Minnesota, United States
    Type
    Buyout

    Align Capital Partners-backed Premier Biotech has acquired GH Solutions, a distributor of point-of-care diagnostic testing products. The deal expands Premier’s customer base and broadens the solutions GH can offer to Premier’s existing network, with focus on government and workplace customers.

  • Premier Biotech (ACP) Acquires OraSure Toxicology Line and Green Earth Biomedical's Mexican Subsidiary (GEM)
    April 10, 2025
    Buyer
    Premier Biotech, Align Capital Partners
    Target
    OraSure Toxicology Line (assets of OraSure Technologies, Inc.), GEM (Mexican subsidiary of Green Earth Biomedical LLC)
    Seller
    OraSure Technologies, Inc., Green Earth Biomedical LLC
    Industry
    Medical Devices
    Location
    Pennsylvania, United States
    Type
    Addon

    Premier Biotech, a portfolio company of Align Capital Partners, acquired certain assets comprising OraSure Technologies' substance abuse testing business line and the Mexican subsidiary of Green Earth Biomedical LLC (GEM). The transactions expand Premier's oral-fluid toxicology product portfolio and accelerate its international distribution footprint in Mexico and Latin America.

  • Premier Biotech Acquires Desert Tox
    June 6, 2024
    Buyer
    Premier Biotech, Align Capital Partners
    Target
    Desert Tox, LLC
    Seller
    Mike Grommes, Mike Gorman
    Industry
    Healthcare Services
    Location
    Arizona, United States
    Type
    Addon

    Premier Biotech, a toxicology testing provider backed by Align Capital Partners, has acquired Desert Tox, LLC, a SAMHSA‑certified laboratory that provides urine and oral fluid testing across HHS/DOT, employment, occupational health and government markets. The founders, Mike Grommes and Mike Gorman, will remain involved; the deal is Premier's first add-on since ACP's acquisition in November 2022 and expands Premier's national service offering and oral fluids capabilities.

Related Acquisition Pages

Healthcare Services Buyers & Acquisitions 4 tracked deals by Premier Biotech. Medical Devices Buyers & Acquisitions 1 tracked deal by Premier Biotech. Acquisitions in Minnesota 2 tracked deals by Premier Biotech. Acquisitions in Arizona 1 tracked deal by Premier Biotech. Acquisitions in Ohio 1 tracked deal by Premier Biotech. Acquisitions in Pennsylvania 1 tracked deal by Premier Biotech.

Related articles

Selling a company? Get in front of buyers like Premier Biotech

Turn tracked acquisition activity into an outreach-ready buyer list.

Find buyers like these →